United States · FDA National Drug Code directory
Sarclisa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0024-0656_7bfd2975-f348-4a3b-890e-63006967b82a
- Product NDC
- 0024-0656
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- isatuximab
- Labeler
- Sanofi-Aventis U.S. LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20200302
- Source listing expiry
- 20271231
Source-listed ingredients
- ISATUXIMAB — 500 mg/25mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (0024-0656-01) / 25 mL in 1 VIAL, SINGLE-DOSE · 0024-0656-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →